Skip to main content
PMC home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1975;86:43–50.

The nature of endotoxin tolerance.

S E Greisman, R B Hornick
PMCID: PMC2441361  PMID: 1179593

Abstract

Certain of the mechanisms by which man develops pyrogenic tolerance to bacterial endotoxins have been considered. After an initial intravenous injection of toxin, two temporally distinct phases of tolerance can be discerned, early and late, each with very different characteristics. Early tolerance appears to be mediated by a non-antibody mechanism entailing a transiently occurring refractory state, apparently involving to a major degree decreased production of endogenous pyrogen by the macrophage system, particularly the hepatic macrophages. Late tolerance appears to be mediated by anti-endotoxin antibodies directed against both "O" and common core antigens which blunt the release of endogenous pyrogen from macrophages. The common core antigens are masked in the presence of the "O" antigenic side chains and become effective immunogens only when these "O" side chains are lacking. Accelerated reticuloendothelial system clearance of circulating endotoxin provides an ancillary protective mechanism in that it brings the toxin more efficiently into the macrophages that are refractory or protected by antibody. When endotoxin is administered repeatedly at closely spaced intervals, both the early phase (non-immune) and late phase (immune) mechanisms may become superimposed. In addition, a third mechanisms, enhanced detoxification capabilities of macrophages, also now appears to come into play. At any given time, it is the relative contribution of each mechanism, which in turn is dependent upon the immunization schedule, antigenicity of the endotoxin, dosage, and immunological competency of the host, that determines the expression of the endotoxin tolerant state.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins E., Bodel P., Francis L. Release of an endogenous pyrogen in vitro from rabbit mononuclear cells. J Exp Med. 1967 Aug 1;126(2):357–384. doi: 10.1084/jem.126.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beeson P. B., Technical Assistance of Elizabeth Roberts TOLERANCE TO BACTERIAL PYROGENS : II. ROLE OF THE RETICULO-ENDOTHELIAL SYSTEM. J Exp Med. 1947 Jun 30;86(1):39–44. doi: 10.1084/jem.86.1.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodel P., Atkins E. Release of endogenous pyrogen by human monocytes. N Engl J Med. 1967 May 4;276(18):1002–1008. doi: 10.1056/NEJM196705042761803. [DOI] [PubMed] [Google Scholar]
  4. Braude A. I., Douglas H. Passive immunization against the local Shwartzman reaction. J Immunol. 1972 Feb;108(2):505–512. [PubMed] [Google Scholar]
  5. CAREY F. J., BRAUDE A. I., ZALESKY M. Studies with radioactive endotoxin. III. The effect of tolerance on the distribution of radioactivity after intravenous injection of Escherichia coli endotoxin labeled with Cr51. J Clin Invest. 1958 Mar;37(3):441–457. doi: 10.1172/JCI103624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GOOD R. A., VARCO R. L. A clinical and experimental study of agammaglobulinemia. J Lancet. 1955 Jun;75(6):245–271. [PubMed] [Google Scholar]
  7. GREISMAN S. E., WOODWARD W. E. MECHANISMS OF ENDOTOXIN TOLERANCE. 3. THE REFRACTORY STATE DURING CONTINUOUS INTRAVENOUS INFUSIONS OF ENDOTOXIN. J Exp Med. 1965 Jun 1;121:911–933. doi: 10.1084/jem.121.6.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greisman S. E., Woodward C. L. Mechanisms of endotoxin tolerance. VII. The role of the liver. J Immunol. 1970 Dec;105(6):1468–1476. [PubMed] [Google Scholar]
  9. Greisman S. E., Young E. J., Carozza F. A., Jr Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. J Immunol. 1969 Dec;103(6):1223–1236. [PubMed] [Google Scholar]
  10. Greisman S. E., Young E. J., DuBuy B. Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer. J Immunol. 1973 Nov;111(5):1349–1360. [PubMed] [Google Scholar]
  11. Greisman S. E., Young E. J. Mechanisms of endotoxin tolerance. VI. Transfer of the "anamnestic" tolerant response with primed spleen cells. J Immunol. 1969 Dec;103(6):1237–1241. [PubMed] [Google Scholar]
  12. Greisman S. E., Young E. J., Woodward W. E. Mechanisms of endotoxin tolerance. IV. Specificity of the pyrogenic refractory state during continuous intravenous infusions of endotoxin. J Exp Med. 1966 Nov 1;124(5):983–1000. doi: 10.1084/jem.124.5.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hahn H. H., Char D. C., Postel W. B., Wood W. B., Jr Studies on the pathogenesis of fever. XV. The production of endogenous pyrogen by peritoneal macrophages. J Exp Med. 1967 Aug 1;126(2):385–394. doi: 10.1084/jem.126.2.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Milner K. C. Patterns of tolerance to endotoxin. J Infect Dis. 1973 Jul;128(Suppl):237–245. doi: 10.1093/infdis/128.supplement_1.s237. [DOI] [PubMed] [Google Scholar]
  15. PAGE A. R., GOOD R. A. Studies on cyclic neutropenia; a clinical and experimental investigation. AMA J Dis Child. 1957 Dec;94(6):623–661. doi: 10.1001/archpedi.1957.04030070035006. [DOI] [PubMed] [Google Scholar]
  16. RUTENBURG S. H., RUTENBURG A. M., SMITH E. E., FINE J. ON THE NATURE OF TOLERANCE OF ENDOTOXIN. Proc Soc Exp Biol Med. 1965 Mar;118:620–623. doi: 10.3181/00379727-118-29921. [DOI] [PubMed] [Google Scholar]
  17. Trejo R. A., Di Luzio N. R. Influence of endotoxin tolerance on detoxification of Salmonella enteritidis endotoxin by mouse liver and spleen. Proc Soc Exp Biol Med. 1972 Nov;141(2):501–505. doi: 10.3181/00379727-141-36808. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES